Edition 73 – Let’s talk about COVID-19 vaccines: Coaching for Provider Confidence
Let’s Talk About COVID-19 Vaccines: Coaching for Provider Confidence By Devon Fisher-Chavez, MS; EunHo Eunice Choi, MS; Surasri Prapasiri, MD, MPH; and Melissa Martinez, MD Facebook Twitter LinkedIn Citation Fisher-Chavez D, Eunice Choi E, Prapasiri S, Martinez M. Let’s talk about COVID-19 vaccines: coaching for provider confidence. HPHR. 2023;73. https://doi.org/10.54111/0001/UUU2 Let’s Talk About COVID-19 Vaccines: […]
Edition 71 – The global economic burden of youth self-harm: A systematic analysis of 204 countries and territories for 2019
Globally, young people (<24 years of age) contribute to about a quarter of the total disease burden of self-harm. However, national strategic plans have been found to have no specific recommendations for managing children and young people suffering from suicidality or preventing youth self-harm. Limited policy attention and allocation of funds can be partially attributed to limited evidence on the economic burden of self-harm. Beyond ethical and health arguments, a high economic burden could persuade policy action. Hence, understanding the global economic burden of youth self-harm including that in low- and middle-income countries (LMICs) is crucial.
Edition 73 – COVID-19 and Malaria Vaccine Advanced Market Commitments: Opportunities to Incentivize Investment in Africa’s Vaccine Manufacturing Industry
This literature review instills a comprehensive understanding of the costs associated with vaccine manufacturing development in the Africa region and draws particular focus to the prices paid by African national governments for the recently rolled out COVID-19 vaccines through the COMAX AMC as well as the estimated costs (based on birth cohort data and DPT vaccination coverage data) of the recently WHO recommended malaria vaccine program.
Edition 73 – Vaccines
This edition addresses the development of vaccines from a health equity and social justice perspective.
